Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Risk Screening Ultimately Reduces Overall Healthcare Costs & Improves Results

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for the early diagnosis of disease is risk screening. So if risk screenings are so valuable, why don’t patients take advantage of these preventative services more often? Let’s take a look.

The High Cost of Waiting

Studies have shown that early detection of certain cancers and other chronic diseases through screening can reduce mortality by 15 to 20 percent. Not only does risk screening prevent complications by diagnosing health conditions early, it can actually help patients—and the healthcare system as a whole—save money. For example, in 2012 Alan Katz, Executive Vice President of SeeChange Health, testified that the average annual cost of early-stage treatment of breast cancer for a single patient is about $14,000 per year compared with $61,000 for late-stage treatment. Other examples of risk screening procedures that help drive down healthcare costs include colonoscopiespulmonary embolism risk assessment, and screenings for obesity, and tobacco and alcohol use.

So Why Isn’t Risk Screening Used More Often?

Out of pocket insurance costs are a top reason more people don’t schedule risk screenings. According to Thompson Reuters, the costs of mammograms, colonoscopies, and MRIs for Americans with employer-sponsored insurance can be two to three times higher than the median price in the same market. In addition, patients may simply be unaware of the specific risk screenings that are available to them because they do not regularly communicate with a primary care physician. Finally, when a patient does decide to get a screening, they may find the process for scheduling an appointment cumbersome and time-consuming.

ChartLogic Has the Tools to Make Scheduling Risk Screenings Easier

ChartLogic’s Connect Patient is a multifunction patient portal and communications platform that works with any device or browser. Physicians and patients can use this powerful technology tool to quickly and easily engage, enhancing the overall patient experience and improving quality by allowing patients to be more active participants in their own care. Patients can easily schedule appointments, send and receive messages from their doctor, view lab results, request prescription refills, and make payments. Best of all, Connect Patient integrates with ChartLogic’s comprehensive ambulatory EHR suite that includes Electronic Medical Records, Practice Management, and Billing Services.

Read more at chartlogic.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's white paper provides a framework for validating digital endpoints in CNS clinical trials, focusing on digital health technologies such as sensors, software, and connected devices. These technologies have the potential to reshape clinical trial endpoints in neurological studies. The white paper aims to guide the integration of digital health solutions in measuring clinical outcomes.

  • 01Digital health technologies like sensors and software can reshape CNS clinical trial endpoints.
  • 02Validating digital endpoints in clinical trials is crucial for integrating technology in CNS studies.
  • 03IQVIA offers a framework for using connected devices in clinical research.

Jul 16, 2026

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

On July 15, significant health technology announcements highlighted advancements in AI safety benchmarks, smarter critical-care equipment, and autonomous front-office tools. These developments indicate a strong push towards integrating intelligent systems in healthcare to enhance patient care and operational efficiency.

  • 01AI safety benchmarks are being established to ensure intelligent technologies are safely integrated into healthcare systems.
  • 02Intelligent ventilators and smarter critical-care tools are being developed to improve patient outcomes in healthcare settings.
  • 03Autonomous front-office tools are being introduced to streamline administrative tasks in healthcare facilities.

Jul 16, 2026

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia is set to expand its healthcare market with expenditures predicted to reach $77.1 billion by 2027, partly driven by advancements in digital health technologies. Digital health revenue is expected to exceed $1 billion by 2029, with an anticipated user base of 16.2 million. This growth represents significant opportunities for enterprise operators in the healthcare sector.

  • 01Saudi Arabia's healthcare spend is projected to reach $77.1 billion by 2027.
  • 02The digital health market in Saudi Arabia is expected to generate over $1 billion in revenue by 2029.
  • 03An estimated 16.2 million users will engage with digital health services in Saudi Arabia by 2029.

Jul 16, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512